Orthofix Medical Inc. Q4 2025 Earnings Call Summary

Performance was anchored by strong results in Bone Growth Therapies (BGT) and U.S. Limb Reconstruction, alongside double-digit growth in Global Spine Fixation. Management successfully transitioned the Spine commercial channel, with the top 30 U.S. distributor partners now driving over 75% of net sales compared to less than 50% in early 2024. The 7D FLASH navigation system continues to serve as a key differentiator, with earnout customers exceeding purchase commitments by more than 50%, validating the ...